It must be noted that NF-κB itself can sustain breast cancer CSC, anthracycline resistance, and drug efflux, as well as the escape of cancer cells from host tissue restrictions and from several components of the immune response [60,61,62,63]. This evidence concerns the gene NFKB1 and breast carcinoma.